Your browser doesn't support javascript.
loading
Effectiveness and safety of reduced-dose fluoropyrimidine therapy in patients carrying the DPYD*2A variant: A matched pair analysis.
Henricks, Linda M; van Merendonk, Lisanne N; Meulendijks, Didier; Deenen, Maarten J; Beijnen, Jos H; de Boer, Anthonius; Cats, Annemieke; Schellens, Jan H M.
Afiliación
  • Henricks LM; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Merendonk LN; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Deenen MJ; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Beijnen JH; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Boer A; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Cats A; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands.
  • Schellens JHM; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.
Int J Cancer ; 144(9): 2347-2354, 2019 05 01.
Article en En | MEDLINE | ID: mdl-30485432

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dihidrouracilo Deshidrogenasa (NADP) / Deficiencia de Dihidropirimidina Deshidrogenasa / Capecitabina / Fluorouracilo / Neoplasias / Antimetabolitos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dihidrouracilo Deshidrogenasa (NADP) / Deficiencia de Dihidropirimidina Deshidrogenasa / Capecitabina / Fluorouracilo / Neoplasias / Antimetabolitos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos